Federal Circuit found that claims covering a naturally occurring composition were not patent eligible under 35 U.S.C. ยง 101 merely because one component of composition had been isolated. ChromaDex, Inc. v. Elysium Health, Inc., Case No. 2022-1116 Federal Circuit Court.